BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Mao W, Fang C, Tian S, Zhu X, Yang L, Huang Z, Li H. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol 2017:S0168-8278(17)32275-4. [PMID: 28887166 DOI: 10.1016/j.jhep.2017.08.032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Luo Y, Huang Z, Mou T, Pu J, Li T, Li Z, Yang H, Yan P, Wu Z, Wu Q. SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway. Life Sci 2021;273:119286. [PMID: 33662429 DOI: 10.1016/j.lfs.2021.119286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Li Y, Fei L, Wang J, Niu Q. Inhibition of miR-217 Protects Against Myocardial Ischemia-Reperfusion Injury Through Inactivating NF-κB and MAPK Pathways. Cardiovasc Eng Technol 2020;11:219-27. [PMID: 31916040 DOI: 10.1007/s13239-019-00452-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
3 Zhang Y, Lei X, Li W, Ding X, Bai J, Wang J, Wu G. TNIP1 alleviates hepatic ischemia/reperfusion injury via the TLR2-Myd88 pathway. Biochemical and Biophysical Research Communications 2018;501:186-92. [DOI: 10.1016/j.bbrc.2018.04.209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Chen W, Zheng D, Mou T, Pu J, Dai J, Huang Z, Luo Y, Zhang Y, Wu Z. Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling. Biosci Biotechnol Biochem 2020;84:1176-82. [PMID: 32114961 DOI: 10.1080/09168451.2020.1735928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yin E, Fukuhara T, Takeda K, Kojima Y, Fukuhara K, Ikejima K, Bashuda H, Kitaura J, Yagita H, Okumura K, Uchida K. Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury. Sci Rep 2021;11:6312. [PMID: 33737554 DOI: 10.1038/s41598-021-85001-2] [Reference Citation Analysis]
6 Zhou J, Hu M, He M, Wang X, Sun D, Huang Y, Cheng X, Fu J, Cai J, Ma T, Tian S, Hu Y, Hu F, Liu D, He Y, Yan L, She ZG, Zhang XJ, Ji YX, Liu H, Li H, Yang H, Zhang P. TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury. Hepatology 2021. [PMID: 34133792 DOI: 10.1002/hep.32015] [Reference Citation Analysis]
7 Zhou J, Qiu T, Wang T, Chen Z, Ma X, Zhang L, Zou J. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. Clin Sci (Lond) 2019;133:335-49. [PMID: 30622220 DOI: 10.1042/CS20180959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang X, Cheng X, Yan Z, Fang J, Wang X, Wang W, Liu Z, Shen L, Zhang P, Wang P, Liao R, Ji Y, Wang J, Tian S, Zhu X, Zhang Y, Tian R, Wang L, Ma X, Huang Z, She Z, Li H. An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury. Nat Med 2018;24:73-83. [DOI: 10.1038/nm.4451] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 20.5] [Reference Citation Analysis]
9 Liu H, Fan J, Zhang W, Chen Q, Zhang Y, Wu Z. OTUD4 alleviates hepatic ischemia-reperfusion injury by suppressing the K63-linked ubiquitination of TRAF6. Biochem Biophys Res Commun 2020;523:924-30. [PMID: 31964525 DOI: 10.1016/j.bbrc.2019.12.114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zeng J, Jin Q, Ruan Y, Sun C, Xu G, Chu M, Ji K, Wu L, Li L. Inhibition of TGFβ-activated protein kinase 1 ameliorates myocardial ischaemia/reperfusion injury via endoplasmic reticulum stress suppression. J Cell Mol Med 2020;24:6846-59. [PMID: 32378287 DOI: 10.1111/jcmm.15340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
11 Zhou J, Chen J, Wei Q, Saeb-Parsy K, Xu X. The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction. Liver Transpl 2020;26:1034-48. [PMID: 32294292 DOI: 10.1002/lt.25779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jianrong S, Yanjun Z, Chen Y, Jianwen X. DUSP14 rescues cerebral ischemia/reperfusion (IR) injury by reducing inflammation and apoptosis via the activation of Nrf-2. Biochemical and Biophysical Research Communications 2019;509:713-21. [DOI: 10.1016/j.bbrc.2018.12.170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
13 Guo WZ, Fang HB, Cao SL, Chen SY, Li J, Shi JH, Tang HW, Zhang Y, Wen PH, Zhang JK, Wang ZH, Shi XY, Pang C, Yang H, Hu BW, Zhang SJ. Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1. Hepatology 2020;71:1037-54. [PMID: 31393024 DOI: 10.1002/hep.30882] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
14 Tao Q, Tianyu W, Jiangqiao Z, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways. Int J Biol Sci 2019;15:1618-29. [PMID: 31360105 DOI: 10.7150/ijbs.33323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Yan Z, Huang Y, Wang X, Wang H, Ren F, Tian R, Cheng X, Cai J, Zhang Y, Zhu X, She Z, Zhang X, Huang Z, Li H. Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice. Hepatology 2019;70:1750-69. [DOI: 10.1002/hep.30705] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
16 Fu J, Zang Y, Zhou Y, Chen C, Shao S, Hu M, Shi G, Wu L, Zhang D, Zhang T. A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype. Biomedicine & Pharmacotherapy 2020;126:110084. [DOI: 10.1016/j.biopha.2020.110084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Hong L, Ai J, Ma D. Activation of Dusp14 protects against osteoclast generation and bone loss by regulating AMPKα-dependent manner. Biochem Biophys Res Commun 2019;519:445-52. [PMID: 31526569 DOI: 10.1016/j.bbrc.2019.07.091] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chen SY, Zhang HP, Li J, Shi JH, Tang HW, Zhang Y, Zhang JK, Wen PH, Wang ZH, Shi XY, He YT, Hu BW, Yang H, Guo WZ, Zhang SJ. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation. Hepatology 2021;73:738-58. [PMID: 32343849 DOI: 10.1002/hep.31295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
19 Cao J, Xu T, Zhou C, Wang S, Jiang B, Wu K, Ma L. NR4A1 knockdown confers hepatoprotection against ischaemia-reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF-κB in mouse hepatocytes. J Cell Mol Med 2021;25:5099-112. [PMID: 33942481 DOI: 10.1111/jcmm.16493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zhang Y, Miao LS, Cai YM, He JX, Zhang ZN, Wu G, Zheng J. TXNIP knockdown alleviates hepatocyte ischemia reperfusion injury through preventing p38/JNK pathway activation. Biochem Biophys Res Commun 2018;502:409-14. [PMID: 29852169 DOI: 10.1016/j.bbrc.2018.05.185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Jiangqiao Z, Tianyu W, Zhongbao C, Long Z, Jilin Z, Xiaoxiong M, Tao Q. Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling. Front Immunol 2020;11:506275. [PMID: 33133065 DOI: 10.3389/fimmu.2020.506275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Huang Z, Zheng D, Pu J, Dai J, Zhang Y, Zhang W, Wu Z. MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway. Biosci Biotechnol Biochem 2019;83:829-35. [PMID: 30686117 DOI: 10.1080/09168451.2019.1569495] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
23 Gao L, Qian B, Chen H, Wang A, Li Q, Li J, Tan P, Xia X, Du Y, Fu W. Hic-5 deficiency attenuates hepatic ischemia reperfusion injury through TLR4/NF-κB signaling pathways. Life Sci 2020;249:117517. [PMID: 32147431 DOI: 10.1016/j.lfs.2020.117517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wu L, Liu Y, Zhao Y, Li M, Guo L. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Free Radic Biol Med 2020;153:140-58. [PMID: 32311490 DOI: 10.1016/j.freeradbiomed.2020.04.009] [Reference Citation Analysis]
25 Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion. Int J Mol Sci 2019;20:E1785. [PMID: 30974915 DOI: 10.3390/ijms20071785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
26 Qiu T, Wang T, Zhou J, Chen Z, Zou J, Zhang L, Ma X. DUSP12 protects against hepatic ischemia-reperfusion injury dependent on ASK1-JNK/p38 pathway in vitro and in vivo. Clin Sci (Lond) 2020;134:2279-94. [PMID: 32803262 DOI: 10.1042/CS20191272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 2020;152:116-41. [PMID: 32156524 DOI: 10.1016/j.freeradbiomed.2020.02.025] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 90.0] [Reference Citation Analysis]